Could stem cells heal a scarred uterus and restore fertility?
NCT ID NCT07176143
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether delivering stem cells from bone marrow directly into the uterine artery can repair severe scarring inside the uterus (intrauterine adhesions) and improve pregnancy rates. Sixty women aged 20-38 with infertility due to this scarring will receive either standard hormone therapy alone or hormone therapy plus the stem cell infusion. Researchers will compare pregnancy success after embryo transfer to see if the stem cell approach is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- human bone marrow mesenchymal stem cells
- What this could lead to
- If it works, this could offer a new treatment for women with severe uterine scarring who cannot get pregnant, potentially improving their chances of having a baby.
- What could go wrong
- This is an early-stage trial with only 60 participants, so results may not apply to everyone. The procedure carries risks like allergic reactions or pain, and the stem cells may not effectively repair the uterus.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAUTERINE ADHESIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.